Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

See Notice to Data Users
Annual data for 2017
Table 1 Reported cases of notifiable diseases and rates - United States, 2017 (Export Data) (PDF)
Table 2 Annual reported cases of notifiable diseases, by geography - United States and Territories, 2017
Table 2a Anthrax;   Arboviral diseases;   (Export Data) (PDF)
Table 2b Arboviral diseases;   (Export Data) (PDF)
Table 2c Arboviral diseases;   Babesiosis;  Botulism;   (Export Data) (PDF)
Table 2d Brucellosis;   Campylobacteriosis;  Chancroid;  Chlamydia trachomatis infection;  Cholera;  Coccidioidomycosis;  Cryptosporidiosis;   (Export Data) (PDF)
Table 2e Cyclosporiasis;   Dengue virus infections;  Diphtheria;  Ehrlichiosis and Anaplasmosis;   (Export Data) (PDF)
Table 2f Giardiasis;   Gonorrhea;  Haemophilus influenzae, invasive disease;  Hansen's disease;   (Export Data) (PDF)
Table 2g Hantavirus infection, non-hantavirus pulmonary syndrome;   Hantavirus pulmonary syndrome;  Hemolytic uremic syndrome post-diarrheal;  Hepatitis;   (Export Data) (PDF)
Table 2h Human immunodeficiency virus diagnoses;   Influenza-associated pediatric mortality;  Invasive pneumococcal disease;  Legionellosis;  Leptospirosis;   (Export Data) (PDF)
Table 2i Listeriosis;   Lyme disease;  Malaria;  Measles;   (Export Data) (PDF)
Table 2j Meningococcal disease;   Mumps;  Novel Influenza A virus infections;   (Export Data) (PDF)
Table 2k Pertussis;   Plague;  Poliomyelitis, paralytic;  Poliovirus infection, nonparalytic;  Psittacosis;  Q fever;   (Export Data) (PDF)
Table 2l Rabies;   Rubella;  Rubella, congenital syndrome;  Salmonellosis;  Severe acute respiratory syndrome-associated coronavirus disease;   (Export Data) (PDF)
Table 2m Shiga toxin-producing Escherichia coli;   Shigellosis;  Smallpox;  Spotted fever rickettsiosis;  Streptococcal toxic shock syndrome;   (Export Data) (PDF)
Table 2n Syphilis;   Tetanus;  Toxic shock syndrome (other than Streptococcal);  Trichinellosis;  Tuberculosis;  Tularemia;   (Export Data) (PDF)
Table 2o Typhoid fever;   Vancomycin-intermediate Staphylococcus aureus;  Vancomycin-resistant Staphylococcus aureus;  Varicella morbidity;  Varicella mortality;  Vibriosis;   (Export Data) (PDF)
Table 2p Viral hemorrhagic fevers;   (Export Data) (PDF)
Table 2q Yellow fever;   Zika virus;   (Export Data) (PDF)
Table 3 Reported cases of notifiable diseases, by month - United States, 2017 (Export Data) (PDF)
Table 4 Reported cases of notifiable diseases and rates, by age group - United States, 2017 (Export Data) (PDF)
Table 5 Reported cases of notifiable diseases and rates, by sex - United States, 2017 (Export Data) (PDF)
Table 6 Reported cases of notifiable diseases and rates, by race - United States, 2017 (Export Data) (PDF)
Table 7 Reported cases of notifiable diseases and rates, by ethnicity - United States, 2017 (Export Data) (PDF)
See also Weekly Tables
Notes:
  • These are annual cases of selected infectious national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published. Cases are reported by state health departments to CDC weekly. Because source datasets may be updated as additional information is received, statistics in publications based on that source data may differ from what is presented in these tables.
  • The list of nationally notifiable infectious diseases and conditions for 2018 and their national surveillance case definitions are available by navigating to the Surveillance Case Definitions | CDC web page, selecting "2017" for the notifiable condition list year, checking "infectious" conditions, and clicking "Get Notifiable List by Year". This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved in 2016 by CSTE for national surveillance, that were implemented in January 2017, including updated surveillance case definitions for salmonellosis, shigellosis, vibrioisis, perinatal hepatitis B virus infection, invasive pneumococcal disease, Lyme disease, and tularemia reported through August 7, 2018. Publication criteria for the finalized 2017 data are available at https://wonder.cdc.gov/nndss/documents/2017_NNDSS_Publication_Criteria.pdf. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Population estimates for incidence rates are July 1st, 2017 estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for April 1, 2010 - July 1, 2017, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino), and sex (Vintage 2017), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states released June 27, 2018 are available at https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Population estimates for territories are the 2017 mid-year estimates from the U.S. Census Bureau International Data Base, accessed on October 2, 2018 at https://www.census.gov/data-tools/demo/idb/informationGateway.php. The choice of population denominators for incidence is based on the availability of population data at the time of publication preparation.
  • Annual tables for 2016 and later years are available on CDC WONDER.
  • Annual summary reports from 1993-2015 are available as published in the MMWR.
  • NNDSS annual tables since 1952 are available at CDC Stacks (once in CDC Stacks select "Annual Reports" in the "Genre" box to the left).
Suggested Citation: